Lannett Company, Inc. (LCI)

1.5600 -0.0800 (-4.88%) At close: 04:02PM EDT

Lannett Company, Inc.

1150 Northbrook Drive
Suite 155
Trevose, PA 19053
United States
215 333 9000
https://www.lannett.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full-time employees: 564

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Timothy C. Crew	CEO & Director	999.47k	N/A	1961
Mr. John Kozlowski	VP of Fin., CFO & Principal Accounting Officer	537.48k	N/A	1972
Mr. John M. Abt	VP and Chief Quality, Information Technology & Operations Officer	491.53k	N/A	1965
Mr. Samuel H. Israel	Gen. Counsel & Chief Legal Officer	526.15k	N/A	1962
Ms. Maureen M. Cavanaugh	Sr. VP & Chief Commercial Operations Officer	551.27k	N/A	1960
Ms. Kristie Stephens	Chief Compliance Officer & VP of Regulatory Affairs	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's product portfolio includes Amphetamine IR tablets, Amphetamine ER capsules, Dicyclomine tablets, Fluphenazine tablets, Levothyroxine capsules, Methylphenidate CD capsules, Methylphenidate ER, Posaconazole DR tablets, Probenecid tablets, and Verapamil SR tablets, as well as Numbrino nasal solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, Sinotherapeutics, Respirent Pharmaceuticals Co., Ltd., HEC Pharm Group, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.

Corporate governance

Lannett Company, Inc.’s ISS governance QualityScore as of 1 February 2023 is 2. The pillar scores are Audit: 3; Board: 3; Shareholder rights: 2; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.